Study Stopped
It corresponds to IDEAL Framework stage 4 and now we are conducting stage 2
Minimally Invasive Open Excisional Hemorrhoidectomy Compared to Conventional Open Excisional Hemorrhoidectomy: a Clinical Trial
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
This study aims to demonstrate that open excisional hemorrhoidectomy (OEH), when performed using a minimally invasive approach, results in less postoperative pain and comparable outcomes to conventional OEH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2024
CompletedFirst Posted
Study publicly available on registry
January 8, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
ExpectedSeptember 3, 2025
August 1, 2025
Same day
December 23, 2024
August 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative pain measured with the visual analogic scale
Postoperative pain presented 10 days after the surgical procedure was measured using the visual analogic scale (VAS). Operationally, a VAS is a horizontal line 100 mm long anchored by word descriptors at each end; on the left-hand end, it says "no pain," and on the right-hand end of the line, it says "very severalPostoperative pain was assessed 10 days after the surgical procedure using the visual analog scale (VAS). The VAS consists of a 100 mm horizontal line, with descriptors at each end. The left end is labeled "no pain," while the right end is labeled "very severe pain." Patients indicate their perception of pain by marking a point on the line. The VAS score is then calculated by measuring the distance in millimeters from the left end of the line to pain". The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring millimetres from the left-hand end of the line to the point the patient marks.
10 days
Postoperative pain measured by the number of rescue painkillers needed
Postoperative pain presented 10 days after the surgical procedure was measured with the number of rescue painkillers needed during this period. Patients will take the following analgesic regimen: Paracetamol 1 gram every 8 hours and Dexketoprofen 12.5 milligrams every 8 hours alternately. Tramadol 50 milligrams will be used as rescue analgesia. The patient will write down the number of Tramadol tablets needed during the first 10 days on a collection sheetPostoperative pain will be assessed 10 days after the surgical procedure by recording the number of rescue painkillers used during this time. Patients will follow this analgesic regimen: they will take Paracetamol 1 gram every 8 hours and Dexketoprofen 12.5 milligrams every 8 hours, alternating between the two. Tramadol 50 milligrams will be available as rescue analgesia. Patients should note the number of Tramadol tablets taken during the first 10 days on a collection sheet..
10 days
Secondary Outcomes (2)
Efficacy of the treatment using the Hemorrhoidal Disease Symptom Score
1 year
Efficacy of treatment using the Short Health Scale adapted for hemorrhoidal disease
1 year
Study Arms (2)
OPEN EXCISIONAL HEMORRHOIDECTOMY
ACTIVE COMPARATORPatients will undergo conventional open excisional hemorrhoidectomy
MINIMALLY INVASIVE OPEN EXCISIONAL HEMORRHOIDECTOMY
EXPERIMENTALPatients will undergo open excisional hemorrhoidectomy using a minimally invasive technique
Interventions
Hemorrhoidectomy performed based on the conventional technique described by Milligan-Morgan
Hemorrhoidectomy performed based on the tecnique described by Milligan Morgan, using a minimally invasive approach.
Eligibility Criteria
You may qualify if:
- Age older than 18 years.
- Hemorrhoids grade III.
- Surgical indication for hemorrhoidal disease.
You may not qualify if:
- Acute hemorrhoidal disease.
- Previous hemorrhoidal surgery.
- Concomitant anal fissure.
- Concomitant anal fistulae.
- Concomitant rectal prolapse.
- Concomitant inflamatory bowel disease or anal cancer.
- Language impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Rorvik HD, Styr K, Ilum L, McKinstry GL, Dragesund T, Campos AH, Brandstrup B, Olaison G. Hemorrhoidal Disease Symptom Score and Short Health ScaleHD: New Tools to Evaluate Symptoms and Health-Related Quality of Life in Hemorrhoidal Disease. Dis Colon Rectum. 2019 Mar;62(3):333-342. doi: 10.1097/DCR.0000000000001234.
PMID: 30451751BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- GENERAL SURGERY SPECIALIST
Study Record Dates
First Submitted
December 23, 2024
First Posted
January 8, 2025
Study Start
February 1, 2026
Primary Completion
February 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
September 3, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share